Latest Breaking News On - Campus research building - Page 1 : comparemela.com

 E-Mail Researchers from the University of Oxford and their partners have today reported findings from a Phase IIb trial of a candidate malaria vaccine, R21/Matrix-M, which demonstrated high-level efficacy of 77% over 12-months of follow-up. In their findings (posted on SSRN/Preprints with The Lancet) they note that they are the first to meet the World Health Organization s Malaria Vaccine Technology Roadmap goal of a vaccine with at least 75% efficacy. The authors report (in findings in press with The Lancet) from a Phase IIb randomised, controlled, double-blind trial conducted at the Clinical Research Unit of Nanoro (CRUN) / Institut de Recherche en Sciences de la Santé (IRSS), Burkina Faso. 450 participants, aged 5-17 months, were recruited from the catchment area of Nanoro, covering 24 villages and an approximate population of 65,000 people.

Region du centre ouestBurkina fasoUnited kingdomUppsala lanCyrus poonawallaMichael makangaHalidou tintoLakshmi mittalAdar poonawallaGareth jenkinsAdrian hillNuffield department of medicineSerum institute of india pvt ltdTimes higher education world university rankingsJenner institute at oxford universityOxford university innovation